New visual scale for meth use: a study
Part of Mental health clinical trials.
This study wants to see if a new picture-based scale can help people accurately describe how much meth they use each day. If you join, you'll fill out a questionnaire and give a small hair sample that will be tested for meth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 40 years old.
- You speak English.
- You have used meth at least once in the last week.
- You have at least one centimeter of untreated hair on the back of your scalp (no chemical treatments).
- Your natural hair color is brown or black.
- You are willing to give a small sample of your hair.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of an investigational drug, CS-1103, to see if it is safe and effective for people who use methamphetamine. It may help understand how the drug affects methamphetamine in the body.
This study gives HIV-positive people who are doing well on HIV medication a small dose of methamphetamine to see how it affects their virus and immune system. Researchers want to understand if methamphetamine can wake up hidden HIV that's not being detected.
This study tests whether a medication called 'Glutide' (a GLP-1 agonist, similar to drugs used for diabetes) can help people who want to stop or cut down on methamphetamine. It's for those with moderate to severe meth use disorder who have used meth on at least 15 of the past 30 days.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
Hear when a new Methamphetamine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.